TRxADE HEALTH, INC. to Report First Quarter 2022 Financial Results on Monday, May 9th at 5:00 p.m. Eastern Time

Rhea-AI Summary

TRxADE HEALTH (NASDAQ:MEDS) will release its financial results for Q1 2022 after the market closes on May 9, 2022. The announcement will be followed by a conference call at 5:00 p.m. Eastern Time to discuss the results, which will include a Q&A session. The company operates a drug procurement marketplace with over 13,475 members, enhancing price transparency and patient engagement through its Bonum Health telehealth services. More details about the conference call and web access can be found on their official site.

Positive

• The company operates a drug procurement marketplace with over 13,475 members.
• Focus on optimizing drug procurement and patient engagement in the U.S.

Negative

• None.

TAMPA, FL / ACCESSWIRE / April 25, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for first quarter 2022, after market close on May 9, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.

In addition, management will host a conference call on Monday, May 9, 2022, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's first quarter 2022 financial results. The call will conclude with a Q&A from participants. To participate, please use the following information:

Q1 2022 Conference Call and Webcast
Date: Monday, May 9, 2022
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13728738
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1541816&tp_key=cbf4963985

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

A playback of the call will be available through June 9, 2022. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally and enter replay pin number 13728738. A webcast will also be available for 30 days on the IR section of the Trxade Group website or by clicking the webcast link above.

About TRxADE HEALTH, INC.

TRxADE HEALTH (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 13,475+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on TRxADE HEALTH, please visit the Company's IR website at investors.trxadegroup.com.

Investor Relations:
IR@trxade.com
Investors.trxadegroup.com

SOURCE: TRxADE HEALTH, Inc.

View source version on accesswire.com:
https://www.accesswire.com/698471/TRxADE-HEALTH-INC-to-Report-First-Quarter-2022-Financial-Results-on-Monday-May-9th-at-500-pm-Eastern-Time

FAQ

When will TRxADE HEALTH release its Q1 2022 financial results?

TRxADE HEALTH will release its Q1 2022 financial results after market close on May 9, 2022.

What time is the conference call for TRxADE HEALTH's Q1 2022 financial results?

The conference call is scheduled for 5:00 p.m. Eastern Time on May 9, 2022.

How can I participate in TRxADE HEALTH's conference call?

To participate, dial 1-877-425-9470 (U.S.) or 1-201-389-0878 (International) and use Conference ID 13728738.

What services does TRxADE HEALTH provide?

TRxADE HEALTH provides a drug procurement marketplace and telehealth services under the Bonum Health brand.

Where can I find the webcast of TRxADE HEALTH's conference call?

The webcast will be available on TRxADE HEALTH's investor relations website for 30 days after the call.